In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the Etest method

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 591-596

  Favel, A ^a   Michel Nguyen, A ^b   Chastin, C ^a   Trousson, F ^b   Penaud, A ^b   Regli, P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ARTICLE; CANDIDA; CANDIDA LUSITANIAE; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG SENSITIVITY; FUNGUS CULTURE; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REPRODUCIBILITY;

AMPHOTERICIN B; CANDIDA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0030925809     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.591     Document Type: Article

References (26)

1. Wingard, J. R. (1995). Importance of Candida species other than C, albicans as pathogens in oncology patients. Clinical Infectious Diseases 20, 115-25.
2. Sanchez, V., Vazquez, J. A., Barth-Jones, D., Dembry, L, Sobel, J. D. & Zervos, M. J. (1992). Epidemiology of nosocomial acquisition of Candida lusitaniae, Journal of Clinical Microbiology 30, 3005-8.
3. Pappagianis, D., Collins, M. S., Hector, R. & Remington, J. (1979). Development of resistance to amphotericin B in Candida lusitaniae infecting a human, Antimicrobial Agents and Chemotherapy 16, 123-6.
4. Ahearn, D. G. & McGlohn, M. S. (1984). In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. Journal of Clinical Microbiology 19, 412-6.
5. Blinkhorn, R. Jn Adelstein, D. & Spagnuolo, P. J. (1989). Emergence of a new opportunistic pathogen, Candida lusitaniae. Journal of Clinical Microbiology 27, 236-40.
6. Hadfield, T. L., Smith, M. B., Winn, R. E., Rinaldi, M. G. & Guerra, C. (1987). Mycoses caused by Candida lusitaniae. Reviews of Infectious Diseases 9, 1006-12.
7. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Proposed Standard M27-P, NCCLS, Villanova, PA.
8. Barchiesi, F., Colombo, A. L., McGough, D. A. & Rinaldi, M. G. (1994). Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. Journal of Clinical Microbiology 32, 2494-500.
9. Fromtling, R. A., Galgiani, J. N., Pfaller, M. A., Espinel-lngroff, A., Bartizal, K. F., Bartlett, M. S. et al. (1993). Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrobial Agents and Chemotherapy 37, 39-45.
10. Pfaller, M. A., Messer, S. A. & Mollis, R. J. (1994), Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagnostic Microbiology and Infectious Disease 20, 127-33.
11. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiology Reviews 6, 367-81.
12. Pfaller, M. A. & Barry, A. L. (1995). In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopathologia 130, 3-9.
13. Warren, N. G. & Hazen, K. C. (1995). Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 723-37. American Society for Microbiology, Washington, DC.
14. Pfaller, M. A., Bale, M., Buschelman, B., Lancaster, M., Espinel-lngroff, A., Rex, J. H., Rinaldi, M. G. et al. (1995). Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. Journal of Clinical Microbiology 33, 1104-7.
15. Drouhet, E., Dupont, B., Improvisi, L., Viviani, M. A. & Tortorano, A. M. (1986). Disc agar diffusion and microplate automatized techniques for in vitro evaluation of antifungal agents on yeasts and sporulated pathogenic fungi. in In Vitro and In Vivo Evaluation of Antifungal Agents (Iwata, K. & Vanden Bossche, H., Eds), pp. 31-49. Elsevier Science Publishers, Amsterdam.
16. AB Biodisk. (1993). Etest Technical Guide No. 4: Antifungal Susceptibility Testing of Yeasts. AB Biodisk, Solna, Sweden.
17. Pfaller, M. A., Vu, Q., Lancaster, M., Espinel-Ingroff, A., Fothergill, A., Grant, C. et al. (1994). Multisite reproducibility of colorimetric broth macrodilution method for antifungal susceptibility testing of the yeast isolates. Journal of Clinical Microbiology 32, 1625-8.
18. Pfaller, M. A. & Barry, A. L. (1994). Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 32, 1992-6.
19. Rex, J. H., Cooper, C. R., Merz, W. G., Galgiani, J. N. & Anaissie, E. J. (1995). Detection of amphotericin B resistant Candida isolates in a broth-based system. Antimicrobial Agents and Chemotherapy 39, 906-9.
20. Wanger, A., Mills, K., Nelson, P. W. & Rex, J. H. (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing; enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrobial Agents and Chemotherapy 39, 2520-2.
21. Espinel-lngroff, A. (1994). Etest for antifungal susceptibility testing of yeasts. Diagnostic Microbiology and Infectious Disease 19, 217-20.
22. Sewell, D. L., Pfaller, M. A. & Barry, A. L. (1994). Comparison of broth macrodilution, broth microdilution, and E test antifungai susceptibility tests for fluconazole. Journal of Clinical Microbiology 32, 2099-102.
23. Espinel-Ingroff, A., Pfaller, M., Erwin, M. E. & Jones, R. N. (1996). Interlaboratory evaluation of Etest method for testing anti-fungal susceptibilities of pathogenic yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose. Journal of Clinical Microbiology 34, 848-52.
24. Colombo, A. L., Barchiesi, F., McGough, D. A., Fothergill, A. W. & Rinaldi, M. G. (1995). Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole. Journal of Antimicrobial Chemotherapy 36, 93-100.
25. Colombo, A. L., Barchiesi, F., McGough, D. A. & Rinaldi, M. G. (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. Journal of Clinical Microbiology 33, 535-40.
26. Van Eldere, J., Joosten, L., Verhaeghe, A. & Surmont, I. (1996). Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test. Journal of Clinical Microbiology 34, 842-7.